FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1304278000: Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Mar 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5309975013 Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5309976014 Canagliflozin 50 mg and metformin hydrochloride 850 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Is a Canagliflozin and metformin only product in oral dose form true Inferred relationship Some
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Oral tablet true Inferred relationship Some
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Metformin hydrochloride true Inferred relationship Some 1
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Metformin hydrochloride true Inferred relationship Some 1
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Canagliflozin true Inferred relationship Some 2
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Canagliflozin true Inferred relationship Some 2
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start